Ginkgo Bioworks Holdings, INC Form 4 insider transactions

Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Mark Dmytruk, CFO of Ginkgo Bioworks Holdings, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units to cover tax obligations.

CFO Mark Dmytruk reports transactions involving Ginkgo Bioworks Class A and Class B common stock, including acquisitions from RSU vesting and a sale to cover tax obligations.

Mark E. Dmytruk, CFO of Ginkgo Bioworks Holdings, Inc., converted 9,497 shares of Class B Common Stock to Class A Common Stock on March 13, 2025.

Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., acquired 4,245 restricted stock units (RSUs) on March 6, 2025, according to a Form 4 filing.

Mark Dmytruk, CFO of Ginkgo Bioworks Holdings, Inc., reported the acquisition of restricted stock units (RSUs) on March 6, 2025.

Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., reports transactions involving Class A Common Stock and Restricted Stock Units.

Mark Dmytruk, CFO of Ginkgo Bioworks, reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units related to vesting and tax obligations.

Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., reports acquisition and disposal of Class A Common Stock and Restricted Stock Units to cover tax obligations.

CFO Mark Dmytruk reports transactions involving Ginkgo Bioworks Holdings, Inc. Class A and Class B Common Stock, including acquisitions, disposals, and conversions related to restricted stock units.

Ginkgo Bioworks' Chief Accounting Officer, Steven P. Coen, executed multiple transactions involving Class A Common Stock and Restricted Stock Units, including sales to cover tax obligations.

Ginkgo Bioworks CFO Mark Dmytruk executed multiple transactions involving Class A Common Stock and Restricted Stock Units, including vesting and sales to cover tax obligations.

Director Harry Sloan acquired 235,780 shares of Ginkgo Bioworks Class A Common Stock through a distribution from Eagle Equity Partners III LLC.

Ginkgo Bioworks' Chief Accounting Officer, Steven P. Coen, sold 330 shares of Class A Common Stock to cover tax obligations following the vesting of restricted stock units.

Ginkgo Bioworks CFO Mark Dmytruk engaged in multiple transactions involving the company's stock, including the vesting of restricted stock units and a sale to cover tax obligations.

Director Harry Sloan acquired 4,222 shares of Ginkgo Bioworks Class A Common Stock through a distribution from Eagle Equity Partners III-G LLC.

Director Sri Kosuri reports the acquisition of stock options and restricted stock units (RSUs) in Ginkgo Bioworks Holdings, Inc.

Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., reports acquisition and disposal of Class A Common Stock and Restricted Stock Units to cover tax obligations.

Mark Dmytruk, CFO of Ginkgo Bioworks Holdings, reports transactions involving Class A and Class B Common Stock, including acquisitions, disposals, and conversions, as well as vesting of Restricted Stock Units.

Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., sold shares to cover tax withholding obligations related to vesting restricted stock units.

CFO Mark Dmytruk reports acquisition and disposal of Ginkgo Bioworks Holdings, Inc. stock, including conversions and sales to cover tax obligations.

Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units to cover tax obligations.

Mark Dmytruk, CFO of Ginkgo Bioworks Holdings, Inc., reports the acquisition and disposal of Class A and Class B Common Stock, as well as Restricted Stock Units, through various transactions including vesting and sales to cover tax obligations.

Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., reports acquisition and disposal of Class A Common Stock and Restricted Stock Units.

Mark Dmytruk, CFO of Ginkgo Bioworks Holdings, reports multiple transactions involving Class A and Class B Common Stock, including acquisitions, disposals, and conversions, according to a Form 4 filing.

Steven P. Coen, Chief Accounting Officer of Ginkgo Bioworks Holdings, Inc., reports the vesting and sale of Class A Common Stock to cover tax obligations.

Mark Dmytruk, CFO of Ginkgo Bioworks Holdings, Inc., reports multiple transactions involving Class A and Class B Common Stock, including acquisitions, disposals, and conversions, according to a Form 4 filing.

Director Harry Sloan reports acquisition and vesting of restricted stock units and stock options in Ginkgo Bioworks Holdings, Inc.

Director Shyam Sankar reports acquisition and vesting of restricted stock units and stock options in Ginkgo Bioworks Holdings, Inc.